Focus on Equities that offer Growth,
Value and Strong Potential Return
Friday, February 27, 2015

Sarepta Therapeutics, Inc.

In-Depth Research Report Available for SRPT

Download Free Report Now

Company Profile SRPT

Sarepta Therapeutics shares declined 3.06 percent to close at $21.83 a share Wednesday. The stock traded between $21.72 and $22.50 on volume of 920,071 shares traded. Analysts at WBB Securities have recently upgraded the company’s rating to “buy” from “speculative buy”. Shares of Sarepta Therapeutics have gained approximately 7.0 percent year-to-date. Going forward ... (see research report)

News & Events SRPT

Fatal error: Class CToolsCssCache contains 1 abstract method and must therefore be declared abstract or implement the remaining methods (DrupalCacheInterface::__construct) in /home/rdi/public_html/sites/all/modules/ctools/includes/ on line 52